Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CDK7-IN-2 is a potent inhibitor of CDK7. CDK7 is involved in transcription initiation using phosphorylation of the Rbpl subunit of RNA polymerase II (RNAPII), which is associated with temporal control of cell cycle and transcriptional activity.CDK7 has research potential for cancer diseases, especially aggressive and difficult-to-treat cancers.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 766.00 | |
50 mg | 6-8 weeks | $ 996.00 | |
100 mg | 6-8 weeks | $ 1,610.00 |
Description | CDK7-IN-2 is a potent inhibitor of CDK7. CDK7 is involved in transcription initiation using phosphorylation of the Rbpl subunit of RNA polymerase II (RNAPII), which is associated with temporal control of cell cycle and transcriptional activity.CDK7 has research potential for cancer diseases, especially aggressive and difficult-to-treat cancers. |
Molecular Weight | 497.63 |
Formula | C26H39N7O3 |
CAS No. | 2326428-19-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CDK7-IN-2 2326428-19-5 inhibitor inhibit